Membrane-bound and soluble αIL-5 receptor mRNA in the bronchial mucosa of atopic and nonatopic asthmatics

American Journal of Respiratory and Critical Care Medicine

Volumn 155, Issue 4, 1997, Pages 1413-1418

  Yasruel, Zivart ^b   Humbert, Marc ^b   Kotsimbos, Thomas C ^b   Ploysongsang, Yongyudh ^b   Minshall, Eleanor ^b   Durham, Stephen R ^b   Pfister, Rudi ^b   Menz, Gunter ^b   Tavernier, Jan ^b   Kay, A Barry ^b   Hamid, Qutayba ^a  

^a MCGILL UNIVERSITY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 5 RECEPTOR; MESSENGER RNA; METHACHOLINE;

ADULT; ARTICLE; ASTHMA; ATOPY; BRONCHUS HYPERREACTIVITY; BRONCHUS MUCOSA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; PRIORITY JOURNAL;

EID: 8244243946     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.155.4.9105087     Document Type: Article

References (31)

1. Wardlaw, A. J., S. Dunnette, G. J. Gleich, J. V. Collins, and A. B. Kay. 1988. Eosinophils and mast cells in bronchoalveolar lavage in mild asthma. Relationship to bronchial hyperreactivity. Am. Rev. Respir. Dis. 137:62-69.
2. De Monchy, J. G., H. F. Kauffman, P. Venge, G. H. Koeter, H. M. Jansen, H. J. Sluiter, and K. De Vries. 1985. Bronchoalveolar eosinophils during allergen-induced late asthmatic reactions. Am. Rev. Respir. Dis. 131:373-376.
3. Azzawi, M., B. Bradley, P. K. Jeffery, A. J. Frew, A. J. Wardlaw, B. Assoufi, J. V. Collins, S. R. Durham, G. K. Knowles, and A. B. Kay. 1990. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am. Rev. Respir. Dis. 142:1407-1413.
4. Tai, P.-C., C. J. F. Spry, C. Peterson, P. Venge, and I. Olsson. 1984. Monoclonal antibodies distinguish between storage and secreted forms of eosinophil cationic peptide. Nature 309:182-184.
5. Gleich, G. J., E. Frigas, D. A. Loegering, D. L. Wassom, and D. Steinmuller. 1979. Cytotoxic properties of the eosinophil major basic protein. J. Immunol. 123:2925-2927.
6. Holgate, S. T., W. M. Abraham, P. J. Barnes, and T. H. Lee. 1989. Pharmacology and treatment. In S. T. Holgate, J. B. L. Hopewell, P. G. J. Burney, J. M. Drazen, F. E. Hargreave, A. B. Kay, K. F. Kerrebijn, and L. M. Reid, editors. The Role of Inflammatory Process in Airway Hyperresponsiveness. Blackwell Scientific Publications, Oxford. 179-221.
7. Clutterbuck, E. J., E. M. A. Hirst, and C. J. Sanderson. 1988. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6 and GM-CSF. Blood 73:1504-1513.
8. Lopez, A. F., C. J. Sanderson, J. R. Gamble, H. R. Campbell, I. G. Young, and M. A. Davas. 1988. Recombinant human interleukin-5 is a selective activator of human eosinophil function. J. Exp. Med. 167:219-224.
9. Yamaguchi, Y., Y. Hayashi, Y. Sugama, Y. Miura, T. Kasahara, S. Kitamura, M. Torisu, S. Mita, A. Tominaga, K. Takatsu, and T. Suda. 1988. Highly purified murine interleukin-5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. J. Exp. Med. 167: 1737-1742.
10. Hamid, Q., M. Azzawi, S. Ying, R. Moqbel, A. J. Wardlaw, C. J. Corrigan, B. Bradley, S. R. Durham, J. V. Collins, P. K. Jeffery, D. J. Quint, and A. B. Kay. 1991. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J. Clin Invest. 87:1541-1546.
11. Robinson, D. S., S. Ying, A. M. Bentley, Q. Meng, J. North, S. R. Durham, A. B. Kay, and Q. Hamid. 1993. Relationships among numbers of bronchoalveolar lavage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms, and airway methacholine responsiveness in atopic asthma. J. Allergy Clin. Immunol. 92:397-403.
12. Bentley, A. M., Q. Meng, D. S. Robinson, Q. Hamid, A. B. Kay, and S. R. Durham. 1993. Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen challenge in atopic asthmatics. Am. J. Respir. Cell Mol. Biol. 8:35-42.
13. Robinson, D. S., Q. Hamid, A. Bentley, S. Ying, A. B. Kay, and S. R. Durham. 1993. Activation of CD4+ T cells, increased Th2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J. Allergy Clin. Immunol. 92:313-324.
14. Robinson, D., Q. Hamid, S. Ying, A. Bentley, B. Assoufi, S. Durham, and A. B. Kay. 1993. Prednisone treatment in asthma is associated with modulation of bronchoalveolar lavage cell interluekin-4, interleukin-5, and interferon-γ cytokine gene expression. Am. Rev. Respir. Dis. 148:401-406.
15. Leung, D. M., R. J. Martin, S. J. Szefler, E. R. Sher, S. Ying, A. B. Kay, and Q. Hamid. 1995. Dysregulation of interleukin-4, interleukin-5, and interferon-γ, gene expression in steroid resistant asthma. J. Exp. Med. 181:33-40.
16. Lopez, A. F., M. A. Vadas, J. M. Woodcock, S. E. Milton, A. Lewis, M. J. Elliott, D. Gillis, R. Ireland, E. Olwell, and L. S. Park. 1991. Interleukin-5, interleukin-3, and granulocyte-macrophage colony stimulating factor cross-complete for binding to cell surface receptors on human eosinophils. J. Biol. Chem. 266:24741-24747.
17. Tavernier, J., R. Devos, S. Cornelis, T. Tuypens, J. Van der Heyden, W. Fiers, and G. Plaetinck. 1991. A human high affinity interleukin-5 receptor (IL-5) is composed of an IL-5-specific α chain and a β chain shared with the receptor for GM-CSF. Cell 66:1175-1184.
18. Murata, Y., S. Takaki, S. Migita, Y. Kikuchi, A. Tominaga, and K. Takatsu. 1992. Molecular cloning and expression of the human interleukin-5 receptor. J. Exp. Med. 175:341-351.
19. Bazan, J. F. 1990. Structural design and molecular evolution of a cytokine receptor superfamily. Proc. Natl. Acad. Sci. U.S.A. 87:6934-6938.
20. Kitamura, T., N. Sato, K. Arai, and A. Miyajima. 1991. Expression cloning of the human IL-3 receptor cDNA reveals a shared β-subunit for human IL-3 and GM-CSF receptors. Cell 66:1165-1174.
21. Tavernier, J., T. Tuypens, G. Plaetinck, A. Verhee, W. Fiers, and R. Devos. 1992. Molecular basis of the membrane-anchored and two soluble isoforms of the human interleukin 5 receptor subunit. Proc. Natl. Acad. Sci. U.S.A. 89:7041-7045.
22. Hamid, Q. 1992. Isotopic localization of cellular mRNA in clinical material using RNA probes. In C. S. Herrington and J. O'D. McGee, editors. Diagnostic Molecular Pathology, a Practical Approach, Vol. I. IRL Press, Oxford. 169-185.
23. Hamid, Q., J. Barkans, Q. Meng, S. Ying, J. S. Abrams, A. B. Kay, and R. Moqbel. 1992. Human eosinophils synthesize and secrete interleukin-6, in vitro. Blood 80:1496-1501.
24. Takagi, M., T. Hara, M. Ichihara, K. Takatsu, A. Miyajima. 1995. Multi-colony stimulating activity of interleukin 5 on haematopoietic progenitors from transgenic mice that express IL-5 receptor a constitutively. J. Exp. Med. 181:889-899.
25. Koike, M., and K. Takatsu. 1994. IL-5 and its receptor: which role do they play in the immune response. Int. Arch. Allergy Immunol. 104: 1-9.
26. Devos, R., Y. Guisez, S. Cornelis, A. Verhee, J. Van der Heyden. M. Manneberg, H.-W. Lahm, W. Fiers, J. Tavernier, and G. Plaetnick. 1993. Recombinant soluble human interleukin-5 (hIL-5) receptor molecules: cross-linking and stoichiometry of binding of IL-5. J. Biol. Chem. 268:6581-6587.
27. Moqbel, R., J. Barkans, B. L. Bradley, S. R. Durham, and A. B. Kay. 1992. Application of monoclonal antibodies against major basic protein (BMK-13) and eosinophil cationic protein (EG1 and EG2) for quantifying eosinophils in bronchial biopsies from atopic asthma. Clin. Exp. Allergy 22:265-273.
28. Zanders, E. D. 1994. Interleukin-5 receptor alpha chain mRNA is down-regulated by transforming growth factor-β1. Soluble or membrane-anchored? Eur. Cytokine Netw. 5:419-422.
29. Devos, R., G. Plaetinck, S. Cornelis, Y. Guisez, J. Van der Heyden, J. Tavernier. 1995. Interleukin-5 and its receptor: a drug target for eosinophilia associated with chronic allergic disease. J. Leukoc. Biol. 57:813-819.
30. Devos, R., Y. Guisez, G. Plaetinck, S. Cornelis, J. Tavernier, J. Van der Heyden, L. H. Foley, and J. E. Scheffler. 1994. Covalent modification of the interleukin-5 receptor isothiazolones leads to inhibition of binding of interleukin-5. Eur. J. Biochem. 225:635-640.
31. Yamaguchi, S., H. Nagai, H. Tanaka, M. Tsujimoto,and N. Tsuruoka. 1994. Time course study for antigen-induced airway hyperreactivity and the effect of soluble IL-5 receptor. Life Sci. 54:471-475.